Mito Health is an AI-native clinic platform that begins with precision diagnostics, offering custom blood panel creation tailored to individual health objectives. The service enables users to bypass preset lab panels and instead communicate their specific testing needs directly to an AI system.
The platform's key feature is its ability to design bespoke lab panels customized for exact health goals within 60 seconds. Users can tell the AI doctor what they want to test, and the system creates a 100% custom biomarker panel. All panels are clinician-designed and AI-interpreted, with results delivered within 2 days across 2,000+ lab locations in the US.
The unique approach involves replacing traditional preset lab panels with conversational AI interaction where users describe their health optimization goals. Instead of choosing from predetermined options, the AI analyzes user requirements and builds panels covering relevant biomarkers while eliminating irrelevant tests. This eliminates the need for multiple lab orders and managing separate PDFs.
The primary benefit is avoiding payment for irrelevant markers while ensuring comprehensive coverage of necessary biomarkers. Users can optimize for specific health areas like fasting, hormones, athletics, or longevity without gaps in data collection. The platform provides clear action steps based on AI interpretation of results.
The service targets individuals seeking personalized health testing across all 50 US states, particularly those interested in biohacking, quantified self-tracking, and precision diagnostics. Future developments include prescription ordering, specialist referrals, lifetime health tracking, and personal AI doctor functionality.
admin
Mito Health serves individuals across all 50 US states who are interested in personalized health testing and optimization. The platform targets biohackers, quantified self-enthusiasts, and people seeking precision diagnostics beyond standard lab panels. Users include those optimizing for specific health areas like fasting, hormones, athletics, or longevity protocols who want to avoid paying for irrelevant markers while ensuring comprehensive coverage of necessary biomarkers.
Updated 2026-02-27